Literature DB >> 33554609

Metformin Is Associated With a Lower Risk of Atrial Fibrillation and Ventricular Arrhythmias Compared With Sulfonylureas: An Observational Study.

Anna Ostropolets1, Pierre A Elias2, Michael V Reyes2, Elain Y Wan2, Utpal B Pajvani2, George Hripcsak1,2, John P Morrow2.   

Abstract

[Figure: see text].

Entities:  

Keywords:  atrial fibrillation; metformin; propensity score; thiazolidinediones; ventricular fibrillation

Mesh：

Substances：

Year:  2021        PMID： 33554609      PMCID： PMC7969445          DOI： 10.1161/CIRCEP.120.009115

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN： 1941-3084


  33 in total

1.  Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.

Authors:  Jeffrey A Johnson; Sumit R Majumdar; Scot H Simpson; Ellen L Toth
Journal:  Diabetes Care       Date:  2002-12       Impact factor: 19.112

2.  Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences.

Authors:  Pei-Jung Lin; David M Kent; Aaron Winn; Joshua T Cohen; Peter J Neumann
Journal:  Am J Manag Care       Date:  2015-01-01       Impact factor: 2.229

3.  Thiazolidinediones are associated with a decreased risk of atrial fibrillation compared with other antidiabetic treatment: a nationwide cohort study.

Authors:  Jannik Langtved Pallisgaard; Tommi Bo Lindhardt; Laila Staerk; Jonas Bjerring Olesen; Christian Torp-Pedersen; Morten Lock Hansen; Gunnar Hilmar Gislason
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2017-07-01

4.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

5.  Comparison of epicardial adipose tissue volume and coronary artery disease severity in asymptomatic adults with versus without diabetes mellitus.

Authors:  Elliott M Groves; Ashwini S Erande; Christine Le; Jonathan Salcedo; Khiet C Hoang; Shivesh Kumar; Dilbahar S Mohar; Farhood Saremi; Jiye Im; Yashwant Agrawal; Pradeep Nadeswaran; Nassim Naderi; Shaista Malik
Journal:  Am J Cardiol       Date:  2014-06-18       Impact factor: 2.778

Review 6.  Adiponectin, the past two decades.

Authors:  Zhao V Wang; Philipp E Scherer
Journal:  J Mol Cell Biol       Date:  2016-03-18       Impact factor: 6.216

7.  Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers.

Authors:  George Hripcsak; Jon D Duke; Nigam H Shah; Christian G Reich; Vojtech Huser; Martijn J Schuemie; Marc A Suchard; Rae Woong Park; Ian Chi Kei Wong; Peter R Rijnbeek; Johan van der Lei; Nicole Pratt; G Niklas Norén; Yu-Chuan Li; Paul E Stang; David Madigan; Patrick B Ryan
Journal:  Stud Health Technol Inform       Date:  2015

8.  Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.

Authors:  Marc A Suchard; Martijn J Schuemie; Harlan M Krumholz; Seng Chan You; RuiJun Chen; Nicole Pratt; Christian G Reich; Jon Duke; David Madigan; George Hripcsak; Patrick B Ryan
Journal:  Lancet       Date:  2019-10-24       Impact factor: 79.321

9.  Interpreting observational studies: why empirical calibration is needed to correct p-values.

Authors:  Martijn J Schuemie; Patrick B Ryan; William DuMouchel; Marc A Suchard; David Madigan
Journal:  Stat Med       Date:  2013-07-30       Impact factor: 2.373

10.  Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative.

Authors:  Rohit Vashisht; Kenneth Jung; Alejandro Schuler; Juan M Banda; Rae Woong Park; Sanghyung Jin; Li Li; Joel T Dudley; Kipp W Johnson; Mark M Shervey; Hua Xu; Yonghui Wu; Karthik Natrajan; George Hripcsak; Peng Jin; Mui Van Zandt; Anthony Reckard; Christian G Reich; James Weaver; Martijn J Schuemie; Patrick B Ryan; Alison Callahan; Nigam H Shah
Journal:  JAMA Netw Open       Date:  2018-08-03
View more
  6 in total

1.  Metformin Reduces Potassium Currents and Prolongs Repolarization in Non-Diabetic Heart.

Authors:  Layse Malagueta-Vieira; Julieta Fernández-Ruocco; María P Hortigón-Vinagre; Víctor Zamora; Julián Zayas-Arrabal; Leyre Echeazarra; Godfrey L Smith; Martín Vila Petroff; Emiliano Medei; Óscar Casis; Mónica Gallego
Journal:  Int J Mol Sci       Date:  2022-05-27       Impact factor: 6.208

2.  Can glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors help in mitigating the risk of atrial fibrillation in patients with diabetes?

Authors:  Sahith Reddy Thotamgari; Udhayvir Singh Grewal; Aakash R Sheth; Akhilesh Babbili; Paari Dominic
Journal:  Cardiovasc Endocrinol Metab       Date:  2022-06-08

3.  Data Consult Service: Can we use observational data to address immediate clinical needs?

Authors:  Anna Ostropolets; Philip Zachariah; Patrick Ryan; Ruijun Chen; George Hripcsak
Journal:  J Am Med Inform Assoc       Date:  2021-09-18       Impact factor: 7.942

Review 4.  Emerging Antiarrhythmic Drugs for Atrial Fibrillation.

Authors:  Arnela Saljic; Jordi Heijman; Dobromir Dobrev
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

5.  Enhancing Fatty Acids Oxidation via L-Carnitine Attenuates Obesity-Related Atrial Fibrillation and Structural Remodeling by Activating AMPK Signaling and Alleviating Cardiac Lipotoxicity.

Authors:  Yudi Zhang; Yuping Fu; Tiannan Jiang; Binghua Liu; Hongke Sun; Ying Zhang; Boyuan Fan; Xiaoli Li; Xinghua Qin; Qiangsun Zheng
Journal:  Front Pharmacol       Date:  2021-11-26       Impact factor: 5.810

Review 6.  Metabolic Inflexibility as a Pathogenic Basis for Atrial Fibrillation.

Authors:  Xinghua Qin; Yudi Zhang; Qiangsun Zheng
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.